DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Dematteo RP, Ballman KV, Antonescu CR et al.
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
Lancet 2009;
373: 1097-1104
We do not assume any responsibility for the contents of the web pages of other providers.